Aspiration & Biopsy Needles Market Know the Scope and Trends

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Aspiration & Biopsy Needles Market- (By Product (Biopsy Needle (Core Biopsy Needles, Vacuum-Assisted Biopsy Needles), Aspiration Needle), By Application (Tumor/Cancer Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Kidney Cancer, Bone & Bone Marrow Cancer, Other Cancers), Wound Applications, Other Applications), By Procedure (Image-Guided (Ultrasound-Guided Procedures, Stereotactic Procedures, CT-Guided Procedures, MRI -Guided Procedures, Other Image-Guided Procedures), Non-image-guided), By End-User (Hospitals & Surgical Centers, Ambulatory Care Centers, Diagnostic Clinics & Pathology Laboratories, Research & Academic Institutes)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Aspiration & Biopsy Needles Market Size is valued at USD 990.65 Mn in 2023 and is predicted to reach USD 1775.98 Mn by the year 2031 at a 7.62% CAGR during the forecast period for 2024-2031.

Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1989

The aspiration and biopsy needles market is experiencing significant growth, primarily driven by the escalating incidence of cancer worldwide. According to the International Agency for Research on Cancer (IARC), there were 17.0 million new cancer cases and 9.5 million cancer-related deaths globally in 2018, with projections indicating an increase to 27.5 million new cases and 16.3 million deaths by 2040.

This surge in cancer prevalence has heightened the demand for effective diagnostic tools, including aspiration and biopsy needles, which are essential for obtaining tissue samples to confirm cancer diagnoses. Minimally invasive procedures, such as fine-needle aspiration (FNA), are increasingly preferred due to their safety, cost-effectiveness, and reduced patient morbidity compared to traditional surgical biopsies.

List of Prominent Players in the Aspiration & Biopsy Needles Market:
• CONMED Corporation (US)
• Medtronic Plc (Ireland)
• Olympus Corporation (Japan)
• Becton, Dickinson and Company (US)
• Boston Scientific Corporation (US)
• Cook Group Incorporated (US)
• Argon Medical Devices, Inc (US)
• INRAD Inc. (US)
• Somatex Medical Technologies (Germany)
• Stryker Corporation (US)
• Cardinal Health (US)
• Remington Medical (US)
• Rantac Corporation (US)
• HAKKO CO., LTD (Japan)
• Merit Medical Systems (US)

Market Dynamics:
Drivers-
The increasing global prevalence of cancer is a primary growth driver in the aspiration and biopsy needles market. Factors such as lifestyle changes, unhealthy dietary habits, and a rise in tobacco consumption have contributed to this trend. According to estimates from the International Agency for Research on Cancer (IARC), there were 17.0 million new cancer cases and 9.5 million cancer-related deaths worldwide in 2018. Projections indicate that by 2040, new cancer cases may rise to 27.5 million with 16.3 million deaths, largely driven by an aging and expanding population.

Curious about this latest version of the report? @
https://www.insightaceanalytic.com/enquiry-before-buying/1989

Challenges:
Current biopsy needle procedures-including core and fine-needle techniques-present certain risks, notably the potential for infection. These risks arise because tissue samples are extracted through incisions, which can expose patients to infectious agents. Additionally, the frequent reuse of needles, particularly in developing regions, further increases the likelihood of infection. Despite recommendations against reusing disposable needles by healthcare professionals and manufacturers, this practice persists, posing a significant challenge for the market.

Regional Trends:
The Asia-Pacific region is emerging as a key growth market for aspiration and biopsy needles, driven by substantial investments in healthcare infrastructure and government-led initiatives to enhance cancer awareness. Moreover, increased efforts by governments and insurance organizations to improve cancer diagnostics and screening, coupled with intensified research activities, are contributing to market expansion. Rapid urbanization and population growth in emerging economies-such as China, India, and South Korea-are expected to further elevate cancer incidence, positioning these markets for robust growth.

Recent Developments:
• In July 2023, Endoscopy clinical division of Cook Medical announces the launch of the EchoTip ProCore® 20 gauge needle with ReCoil StyletTM, the newest addition to the EchoTip ProCore® product portfolio. The flexible design of this needle enables physicians to acquire histological samples from challenging anatomical locations1.
• In Jan 2021, SOMATEX Medical Technologies GmbH was acquired by Hologic, Inc. for about $64 Mn, according to the company's announcement. SOMATEX provided Hologic with additional knowledge and skills to continue expanding its breast health portfolio by specialising in the development and production of minimally invasive devices in the fields of cancer diagnosis, biopsy, and interventional specialty.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1989

Segmentation of Aspiration & Biopsy Needles Market-
By Product-
• Biopsy Needle
o Core Biopsy Needles
o Vacuum-Assisted Biopsy Needles
• Aspiration Needle
By Application-
• Tumor/Cancer Application
o Breast Cancer
o Lung Cancer
o Colorectal Cancer
o Prostate Cancer
o Kidney Cancer
o Bone & Bone Marrow Cancer
o Other Cancers
• Wound Applications
• Other Applications
By Procedure-
• Image-Guided
o Ultrasound-Guided Procedures
o Stereotactic Procedures
o CT-Guided Procedures
o MRI -Guided Procedures
o Other Image-Guided Procedures
• Non-image-guided
By End-User-
• Hospitals & Surgical Centers
• Ambulatory Care Centers
• Diagnostic Clinics & Pathology Laboratories
• Research & Academic Institutes
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Get More Information: @
https://www.insightaceanalytic.com/report/aspiration--biopsy-needles-market/1989

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.